Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.
about
Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK PathwayNever in mitosis gene A related kinase-6 attenuates pressure overload-induced activation of the protein kinase B pathway and cardiac hypertrophyRemodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.Alcohol effects on cardiac function.Myocardial reverse remodeling: how far can we rewind?Hypoxia in tissue repair and fibrosis.Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure.Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.Molecular mechanisms in microRNA-mediated TRB3 gene and hypertension left ventricular hypertrophy.Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia.Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathwayBrief Communication: Copper suppression of vascular endothelial growth factor receptor-2 is involved in the regression of cardiomyocyte hypertrophy.Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat.Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling.Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1β.The Association Between Myocardial Fibrosis and Depressed Capillary Density in Rat Model of Left Ventricular Hypertrophy.Nanocurcumin protects cardiomyoblasts H9c2 from hypoxia-induced hypertrophy and apoptosis by improving oxidative balance.Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice.Using phosphoproteomics to monitor disregulated signaling networks in cardiac disease preceding heart failure.
P2860
Q28552721-217FB4B0-4201-49BE-976D-8BCC92545BADQ35157232-FFCF0DED-0807-441E-AE4C-AC9D9D21D8E8Q38169962-A4884058-0E71-47A9-BE41-9453310050D6Q38423870-B1848C76-A4FA-46EF-9C83-06777D84D74DQ38780883-6FF64405-1C62-4BDD-97DF-DCB126B79B25Q38898935-855751DB-F316-43A6-9DAF-05C370CF5EDDQ41049541-621DC2C2-C1B6-4608-B0D0-B1FA2CADAEDBQ41125719-DC028EE7-E27D-4AE1-8B86-E98A69DCAB07Q41189484-CF170BF5-9CFA-44FB-A774-CB3AFED3CE24Q41870120-19116823-0B8E-4D72-8AEA-1DB9943EC4BFQ42256339-7C8E05C9-C4D7-4B6C-8979-DCE4B83D93EFQ42679042-9C72469E-0B4A-46A6-B195-0501381F1E02Q42705343-E3148CEF-D1F6-4195-B426-765E95FBB51FQ46236892-4FC30950-2895-4D71-81DA-5B15C1BA6A37Q47098056-A596959E-E5E3-4962-9B37-2C0B853697F1Q50026322-9049F68B-5548-445B-ADF7-224E22A70B0AQ50076648-70AB42CC-A86A-4B18-83D7-3EDFA100D59DQ51643206-36E5F632-9652-4AC2-9C43-07EC4570BD24Q52691424-93AE0098-735E-44DA-9E35-F6A52E702D9FQ54505379-5D4EB22F-8451-4645-B5ED-BEFDC994C371
P2860
Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Regression of pathological car ...... hways and therapeutic targets.
@ast
Regression of pathological car ...... hways and therapeutic targets.
@en
type
label
Regression of pathological car ...... hways and therapeutic targets.
@ast
Regression of pathological car ...... hways and therapeutic targets.
@en
prefLabel
Regression of pathological car ...... hways and therapeutic targets.
@ast
Regression of pathological car ...... hways and therapeutic targets.
@en
P2860
P1476
Regression of pathological car ...... hways and therapeutic targets.
@en
P2093
Jianglong Hou
Y James Kang
P2860
P304
P356
10.1016/J.PHARMTHERA.2012.06.006
P577
2012-06-29T00:00:00Z